Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis.
Despite intensive therapy, approximately 60-80% of children who are diagnosed with metastatic neuroblastoma (NB) succumb to the disease. NB preferentially metastasizes to the bone marrow (BM). In the present study we used SY5Y and CHP212 (NB cell lines) to study the roles of the preprotachykinin-I (PPT-I) gene and the natural receptors for PPT-I peptides, neurokinin-1 (NK-1) and NK-2, in the biology of NB. PPT-I, NK-1 and NK-2 were constitutively expressed in the NB cells. Functional studies, with specific NK receptor antagonists, showed that PPT-I peptides mediate autocrine proliferation of the NB cells through both NK-1 and NK-2 receptors. Full-length and truncated NK-1 receptors were detected in NB cells. Since there is one copy of the NK-1 gene, we used NK-1-specific siRNA to suppress the expression of NK-1. The NK-1-deficient NB cells showed phenotypes consistent with cell differentiation. Suppression of NK-1 did not appear to cause cell death, as demonstrated by trypan blue exclusion and by undetectable active caspase. NK-1 suppression reduced the proliferation of the NB cells beginning by 10-fold at day 1 and reached a 10(5)-fold reduction by day 10. The NK-1 deficient cells did not proliferate when they were placed as cocultures with BM stroma, which suggests that NK-1 signaling is important for the survival of NB cells in the BM. The results show potential roles for NK receptors in the proliferation of NB.
Mukerji
Indroneil
I
New Jersey Medical School (UMDNJ-NJMS), Department of Medicine - Hematology/Oncology, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, MSB, Room E-579, Newark, NJ 07103, USA.
Ramkissoon
Shakti H
SH
Reddy
Kavitha K R
KK
Rameshwar
Pranela
P
D019898:Autocrine Communication; D001854:Bone Marrow Cells; D019046:Bone Marrow Neoplasms / Q000556:secondary*; D002455:Cell Division; D045744:Cell Line, Tumor; D018920:Coculture Techniques; D006801:Humans; D009423:Nervous System Neoplasms / Q000473:pathology*; D009447:Neuroblastoma / Q000473:pathology* / Q000556:secondary*; D011498:Protein Precursors / Q000378:metabolism*; D034741:RNA, Small Interfering; D018040:Receptors, Neurokinin-1 / Q000235:genetics / Q000378:metabolism*; D018041:Receptors, Neurokinin-2 / Q000378:metabolism*; D017154:Stromal Cells; D015320:Tachykinins / Q000378:metabolism*; D014162:Transfection
D011498:Protein Precursors; D034741:RNA, Small Interfering; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; D015320:Tachykinins; C044206:preprotachykinin